EN

Anti-Human IgG(CH3 Fragment specific), AlpSdAbs® VHH(iFluor647 ×4)

Anti-Human IgG(CH3 Fragment specific), AlpSdAbs® VHH(iFluor647 ×4)
Anti-Human IgG(CH3 Fragment specific), AlpSdAbs® VHH(iFluor647 ×4)
Details and Advantages

Code: 023-113-009

Size: 100ug / 1mg

Applications: WB,ELISA,ICC/IF,Flow Cyt

Specificity: Human IgG(CH3 Fragment specific)

Conjugate: iFluor647

Advantages:

  • High lot-to-lot consistency

  • Increased sensitivity and higher affinity

  • Animal-free production

Product Detail

Product Overview

The Anti-Human IgG (CH3 Fragment Specific), AlpSdAbs® VHH (iFluor647 ×4) is a recombinant, monoclonal single-domain antibody conjugated to iFluor647, engineered for highly specific detection of the CH3 fragment of human IgG Fc. Validated across immunoelectrophoresis and ELISA, this nanobody-based secondary reagent delivers high sensitivity with low background, making it an ideal tool for rapid pre-selection of internalizing antibodies before formal ADC development.


Properties

Parameter

Specification

Immunogen

Human IgG                    

Host

Alpaca pacous

Isotype

VHH domain of alpaca IgG2b/2c  

Conjugate

iFluor647(Ex:651nm, Em:667nm)  

Specificity

Human IgG(CH3 Fragment specific)

Cross-Reactivity

Recognizes human IgG CH3 fragment specifically, and reacts with cynomolgus IgG. No Cross-reactivity to rabbit , mouse, rat, goat IgG      

Purity

Recombinant Expression and Affinity purified

Concentration

1mg/ml

Formation

Liquid, 10mM PBS (pH 7.5), 0.05% sucrose, 0.1% trehalose, 0.01% proclin300, 50% glycerol

Storage

Store at –20 °C(Avoid freeze / thaw cycles) , Protect from light.

 

Key Advantage

High Lot-to-Lot Consistency: Recombinant production ensures reproducible performance across experiments and batches, a critical requirement for regulated research environments.

Increased Sensitivity and Higher Affinity: The VHH single-domain format (<15 kDa) provides superior tissue and cellular permeability compared to conventional antibody fragments, enhancing signal quality in imaging and cytometric applications.

Low Background and High Sensitive:  Nano-secondary conjugates demonstrate high specificity and minimal non-specific cytotoxicity, with no significant interference with primary antibody activity when used in combination assays.

Compatible with Multiple Human IgG Subclasses: Detects IgG1, IgG2, IgG3, and IgG4 via CH3 fragment recognition, providing broad utility across antibody research programs.

More Stability: high-affinity nanobodies (nM level) ensure rapid and stable formation of antibody-toxin conjugates.

High-throughput: Suitable for high-sensitivity and high-throughput immunotoxin conjugate killing detection for hybridoma supernatant stage screening.


Application & Recommended Usage

Validated Applications and Recommended Dilutions

This reagent is validated for use across the following platforms:

Application

Recommended Dilution

Flow Cyt

1:200-1:2000

ICC/IF

1:200-1:2000

ELISA

1:5000-1:20000

WB

1:5000-1:20000

Super-resolution microscopy

 none

 

Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc. The actual dilution used must be determined empirically.

 

ADC Internalization Screening Application

For laboratories conducting ADC development programs, this reagent supports rapid pre-screening of candidate internalizing antibodies when used as part of a Nano-Secondary ADC workflow. VHH nano-secondary conjugates enable evaluation of internalization-dependent cytotoxicity, comparison of internalization efficiency among multiple antibody candidates, and support of high-throughput screening in tumor cell models — providing a cost-effective alternative prior to formal ADC development.

 

Target Background

In mammals, antibodies are classified into five main classes or isotypes – IgA, IgD, IgE, IgG and IgM. They are classed according to the heavy chain they contain – alpha, delta, epsilon, gamma or mu respectively. IgG is the most abundant antibody in normal human serum, accounting for 70-85% of the total immunoglobulin pool. Human IgG consists of four human subclasses (IgG1, IgG2, IgG3 and IgG4), and each contains a different heavy chain. The whole IgG molecule possesses both the Fc region and the Fab region, which possessing the epitope-recognition site. The IgG contains two heavy and light chains(kappa or lambda). The heavy chain is about 50 KD and the light chain is about 25 KD. The common IgG is monomeric with a molecular weight of approximately 150 kD.

VHH are single-domain antibodies derived from the variable regions of heavy chain of Camelidae immunoglobulin. The size of VHH is extremely small(<15KDa) compared to other forms of antibody fragment, which significantly increase the permeability of VHH. Thus VHH is considered of great value for research, diagnostics and therapeutics.


Ready to Streamline Your Antibody Detection or ADC Screening Workflow?

Whether you are characterizing therapeutic antibodies, developing ADC candidates, or optimizing imaging protocols, the AlpSdAbs® VHH (iFluor647 ×4) secondary nanobody delivers the specificity, consistency, and sensitivity your research demands.

Request a Quote

→ Download the Full Technical Datasheet

→ Contact Our Scientific Support Team

Anti-Human IgG(CH3 Fragment specific), AlpSdAbs® VHH(iFluor647 ×4)


FAQ

Citations

Consult

Contact

Telephone:

+86 138 8067 6215

Address:

Building 16, No.99 Haiwang Road, Wenjiang, Chengdu, China 611130